Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular Lymphoma
Merryman R, Michaud L, Redd R, Mondello P, Park H, Spilberg G, Robertson M, Taranto E, Ahmed G, Chase M, Jeter E, Ahn I, Brown J, Crombie J, Davids M, Fisher D, Jacobsen E, Jacobson C, Kim A, LaCasce A, Ng S, Odejide O, Parry E, Salles G, Zelenetz A, Armand P, Schöder H, Jacene H. Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular Lymphoma. HemaSphere 2023, 7: e826. PMID: 36713355, PMCID: PMC9875968, DOI: 10.1097/hs9.0000000000000826.Peer-Reviewed Original ResearchInterim positron emission tomographyProgression-free survivalPositron emission tomographyDeauville scoreFollicular lymphomaFrontline chemoimmunotherapyMultivariable analysisSignificant predictorsResponse-adapted treatment strategiesTreatment positron emission tomographyInferior progression-free survivalEmission tomographyMaximum standardized uptake valueHigh-grade follicular lymphomaHigh-risk patientsSubset of patientsStandardized uptake valueProgression of diseaseMost patientsIndependent predictorsExcellent outcomesEarly progressionTreatment strategiesEarly predictorSeparate cohort